Status and phase
Conditions
Treatments
About
evaluate the efficacy and safety of DWJ211 in patient with moderate or severe submental fat
Full description
DWJ211
_ reduction of moderate or severe submental fat
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
140 participants in 4 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal